| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/01/2010 | WO2010030980A3 Akt and clusterin as biomarkers of chemotherapeutic responsiveness |
| 07/01/2010 | WO2009051801A3 Chemical inhibitors of inhibitors of differentiation |
| 07/01/2010 | US20100168381 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 07/01/2010 | US20100168215 Methods and compositions for the treatment of neurological disease |
| 07/01/2010 | US20100168214 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
| 07/01/2010 | US20100168052 Treatment of EBV and KHSV Infection and Associated Abnormal Cellular Proliferation |
| 07/01/2010 | US20100168047 Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics |
| 07/01/2010 | US20100168027 Bpc-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 07/01/2010 | US20100167352 Infectious clones |
| 07/01/2010 | US20100166791 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 07/01/2010 | US20100166724 Uses of thioredoxin |
| 07/01/2010 | US20100166704 Methods and compositions for inhibition of viral replication |
| 07/01/2010 | US20100166703 Use of il-6/il-6 chimera in huntington's disease |
| 06/30/2010 | EP2202315A1 Modified vaccinia ankara virus variant |
| 06/30/2010 | EP2202308A2 Methods and compositions for polypeptide engineering |
| 06/30/2010 | EP2202297A1 Use of a chemotherapeutic agent in the preparation of a medicament for treating or ameliorating an adverse side effect associated with oncolytic viral therapy |
| 06/30/2010 | EP2202242A1 Inactivation resistant factor VIII related applications |
| 06/30/2010 | EP2202241A2 Therapeutic compounds and methods for modulating V3, a versican isoform |
| 06/30/2010 | EP2200649A2 Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss |
| 06/30/2010 | EP2200592A2 Adhering troches with topically active ingredients for treatment of throat, esophagus, and stomach |
| 06/30/2010 | EP1622648B1 Dna vaccines against tumor growth and methods of use thereof |
| 06/30/2010 | EP1531180B1 Method of diagnosing risk of myocardial infarction |
| 06/30/2010 | EP1399183B1 Chimeric alphavirus replicon particles |
| 06/30/2010 | CN1966082B Genetic medicine for preventing and treating cancer of colon and rectum, preparation process and use thereof |
| 06/30/2010 | CN101760475A Recombinant retroviral vector |
| 06/30/2010 | CN101760474A EMX2 adenovirus vector and application thereof |
| 06/30/2010 | CN101760457A SiRNA inhibiting duplication of A type influenza virus and coding sequence thereof |
| 06/30/2010 | CN101759170A Magnetic nano sheet-shaped hydroxyapatite and preparation method and application thereof |
| 06/30/2010 | CN101756903A Preparation process of nanometer magnetic drug-carrying gene-carrying thermal controlled release liposome |
| 06/30/2010 | CN101210044B Polypeptide and application thereof |
| 06/30/2010 | CN101199861B DNA vaccine for resisting liver cancer |
| 06/30/2010 | CN101168064B Recombination human pancreatic cancer mucus protein core peptide DNA vaccine |
| 06/29/2010 | US7745651 liposomes; nucleic acid lipid particles; gene therapy; improved membrane fluidity |
| 06/29/2010 | US7745611 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA |
| 06/29/2010 | US7745608 Conjugated lipophilic group with a modified nucleotide is used to target disease gene, cells, tissue, for drug delivery to entrance into tumor cells; ribose sugar of nucleotide is replaced with a cyclic carrier which has at least one attached phosphate or phosphorothioate group; antitumor biodrugs |
| 06/29/2010 | US7745581 T-bet compositions and methods of use thereof |
| 06/29/2010 | US7745485 Inhibiting metastasis of cancer cells by administering a phosphatidyl inositol 3-kinase inhibitor such as Wortmannin or LY294002 (2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one) |
| 06/29/2010 | US7745416 Method for in vivo regulation of cardiac muscle contractility |
| 06/29/2010 | US7745406 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders |
| 06/29/2010 | US7745405 Cancer treatment by administration of a synthetic peptide comprising a sequence of amino acids within the p53 protein and a membrane penetrating leader sequence; fusion proteins for tissue-targeted therapy |
| 06/29/2010 | US7745395 Recombinant protease comprising prostate-specific protease cleavage site and deficient in furin cleavage site for use as therapeutic agent in treatment of cell proliferative disorders; antitumor agents |
| 06/29/2010 | US7745214 for assessing the effect of candidate chemotherapeutic drugs on the growth of brain tumors; fibroblast growth factor expressing cells and diagnosis and treatment of tumors; antiproliferative agents |
| 06/29/2010 | US7745179 Lentiviral producer cell; such as mounse transthyretin (mTTR) promoter (antibody); recombinant lentiviruses and transfer vectors for transgene delivery and gene therapy; blood coagulation factor IX; antihemopohilic factor |
| 06/29/2010 | US7745174 co-expressing two heterotypes of Hepatocyte Growth Factor (HGF) comprising transforming or transfecting to a cell a DNA construct; for prevention and treatment of ischemic and liver disorders |
| 06/29/2010 | US7745156 Methods for diagnosis and treatment of epithelial-derived cancers |
| 06/29/2010 | US7745114 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 06/29/2010 | US7745109 Regulation of cell growth by MUC1 |
| 06/29/2010 | US7744927 Methods of promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 06/29/2010 | US7744899 Preferentially kills tumor cells and not healthy cells; expresses only one gamma 134.5 gene copy and that comprises an expressibletumor-growth-inhibiting cytokine-encoding DNA; anticarcinogenic agents; antitumor agents; nervous system disorders; immunotherapy;tissue-targeted therapy |
| 06/29/2010 | US7744896 therapeutic vaccine anti-HIV, anti-AIDS and against tumors and syndromes associated with HIV infection |
| 06/29/2010 | CA2452471C Enhancement of transfection of dna into the liver |
| 06/29/2010 | CA2401942C Pharmaceutical compositions for buccal and pulmonary application |
| 06/29/2010 | CA2370477C Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 06/29/2010 | CA2358439C Metastasis models using green fluorescent protein (gfp) as a marker |
| 06/29/2010 | CA2326373C Methods and substances for preventing and treating autoimmune disease |
| 06/29/2010 | CA2289600C Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes |
| 06/29/2010 | CA2274498C Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 06/29/2010 | CA2236700C Immunity against pasteurella haemolytica leukotoxin |
| 06/29/2010 | CA2187740C Dna encoding bradykinin b1 receptor |
| 06/24/2010 | WO2010071832A1 Delivery of polynucleotides across the blood brain barrier using recombinant aav9 |
| 06/24/2010 | WO2010071454A1 Adeno-associated viral vectors and uses thereof |
| 06/24/2010 | WO2010070877A1 Elovl7 epitope peptides and vaccines containing the same |
| 06/24/2010 | WO2010069204A1 Pluripotent stem cells, method for preparation thereof and uses thereof |
| 06/24/2010 | WO2009089401A3 Compositions comprising toll-like receptor or coreceptor antagonists and methods for treating or controlling ocular allergy using same |
| 06/24/2010 | US20100160611 Human skeletal muscle-specific ubiquitin-conjugating enzyme |
| 06/24/2010 | US20100159592 Emulsion compositions |
| 06/24/2010 | US20100159525 Extranuclear RNA Splicing in Neuronal Dendrites |
| 06/24/2010 | US20100159453 Genes involved in intestinal inflammatory diseases and use thereof |
| 06/24/2010 | US20100159439 Method for combined sequential agent delivery and electroporation for cell structures and use thereof |
| 06/24/2010 | US20100159030 Methods for detecting and modulating the sensitivity of tumor cells to anti-mitotic agents and for modulating turmorgenicity |
| 06/24/2010 | US20100158907 Connective tissue growth factor fragments and methods and uses thereof |
| 06/24/2010 | US20100158868 Use of Fetal Cells for the Treatment of Genetic Diseases |
| 06/24/2010 | US20100158867 Paramyxovirus vector encoding angiogenesis gene and use thereof |
| 06/24/2010 | DE102008063606A1 New nucleic acid construct, comprising first and second expression cassette comprising operatively linked e.g. constitutive expressing promoter, and minimal promoter, respectively, useful to prepare a product e.g. polypeptide or ribozyme |
| 06/24/2010 | CA2706317A1 Doc1 compositions and methods for treating cancer |
| 06/23/2010 | EP2199392A2 Genetic modification of somatic cells and uses thereof |
| 06/23/2010 | EP2199299A2 Antisense modulation of survivin expression |
| 06/23/2010 | EP2199298A1 Sirna silencing of Apolipoprotein B |
| 06/23/2010 | EP2198891A1 Method for promoting the expression of p53, and p53 expression promoter for use in the method |
| 06/23/2010 | EP2198882A2 Nucleic acid mucosal immunization |
| 06/23/2010 | EP2198041A1 Method and composition for cancer diagnosis and treatment |
| 06/23/2010 | EP2198021A1 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis |
| 06/23/2010 | EP2198016A1 Porcine adeno-associated viruses |
| 06/23/2010 | EP2198011A1 Wnt pathway stimulation in reprogramming somatic cells |
| 06/23/2010 | EP2197497A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |
| 06/23/2010 | EP1613348B1 Methods for modulating angiogenesis with apelin compositions |
| 06/23/2010 | EP1572748B1 Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2 |
| 06/23/2010 | EP1108036B1 Dengue viruses that are replication defective in mosquitos for use as vaccines |
| 06/23/2010 | CN1845993B Interfering RNA duplex having blunt-ends and 3'-modifications |
| 06/23/2010 | CN1824773B Human testicle specificity protein 50 gene expression regulator screening system and method of screening its gene expression regulator |
| 06/23/2010 | CN1655827B Novel use of adenoviruses and nucleic acids coding therefor |
| 06/23/2010 | CN101748151A Recombinant human hepatitis C virus antigen adenoviral vector and applications thereof |
| 06/23/2010 | CN101748140A Schistosoma japonica glyceraldehyde-3-phosphate dehydrogenase gene and encoded protein and application thereof |
| 06/23/2010 | CN101748139A Schistosoma japonica enolase gene and coding protein and application thereof |
| 06/23/2010 | CN101748138A Schistosoma japonica superoxide dismutase gene and a coding protein and application thereof |
| 06/23/2010 | CN101748128A Schistosoma japonica titin gene and coding protein and application thereof |
| 06/23/2010 | CN101748127A Schistosoma japonica actin gene and a coding protein and application thereof |
| 06/23/2010 | CN101748125A siRNA segment and application thereof used for curing and/or preventing Porcine Reproductive and Respiratory Syndrome |
| 06/23/2010 | CN101748124A siRNA segment and application thereof used for curing and/or preventing Peste des petits ruminants |
| 06/23/2010 | CN101748122A Disturbing molecule for inhibiting expression of TM4SF4 and application thereof |